ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Organoids technology for advancing the clinical translation of cancer nanomedicine

Zhao, Dong-Kun; Liang, Jie; Huang, Xiao-Yi*; Shen, Song*; Wang, Jun*
Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology2023-9DOI: 10.1002/wnan.1892
2被引5阅读
引用收藏
分享

摘要

The past decades have witnessed the rapid development and widespread application of nanomedicines in cancer treatment; however, the clinical translation of experimental findings has been low, as evidenced by the low percentage of commercialized nanomedicines. Incomplete understanding of nanomedicine-tumor interactions and inappropriate evaluation models are two important challenges limiting the clinical translation of cancer nanomedicines. Currently, nanomedicine-tumor interaction and therapeutic effects are mainly investigated using cell lines or mouse models, which do not recapitulate the complex tumor microenvironment in human patients. Thus, information obtained from cell lines and mouse models cannot provide adequate guidance for the rational redesign of nanomedicine. Compared with other preclinical models, tumor organoids constructed from patient-derived tumor tissues are superior in retaining the key histopathological, genetic, and phenotypic features of the parent tumor. We speculate that organoid technology would help elucidate nanomedicine-tumor interaction in the tumor microenvironment and guide the design of nanomedicine, making it a reliable tool to accurately predict drug responses in patients with cancer. This review highlighted the advantages of drug delivery systems in cancer treatment, challenges limiting the clinical translation of antitumor nanomedicines, and potential application of patient-derived organoids (PDO) in nanomedicine. We propose that combining organoids and nanotechnology would facilitate the development of safe and effective cancer nanomedicines and accelerate their clinical application. This review discussed the potential translational value of integrative research using organoids and cancer nanomedicine.This article is categorized under:Nanotechnology Approaches to Biology > Nanoscale Systems in BiologyTherapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease

学科与关键词

关键词
clinical translationnanomedicinepatient-derived organoidsprecision medicinetumor organoid
相关
加载中…
  • Organoids for Cancer Research: Advances and Challenges
    Xin, Miaomaio; Li, Qian*; Wang, Dongyang; Wang, Zheng*ADVANCED BIOLOGY, 2024, 8(9).
  • Organoids and organs-on-chips: insights into predicting the efficacy of systemic treatment in colorectal cancer
    Zhu, Jialong; Ji, Linlin; Chen, Yitian; Li, Huiyu; Huang, Mengxi; Dai, Zhe; Wang, Jing; Xiang, Dan; Fu, Gongbo*; Lei, Zengjie*; Chu, Xiaoyuan*Cell Death Discovery, 2023, 9(1): 72.被引 7
  • The pivotal application of patient-derived organoid biobanks for personalized treatment of gastrointestinal cancers
    Yu, Ya-ya; Zhu, Yan-juan; Xiao, Zhen-zhen; Chen, Ya-dong; Chang, Xue-song; Liu, Yi-hong; Tang, Qing; Zhang, Hai-bo*Biomarker Research, 2022, 10(1): 73.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
发表日期
2023-09
卷期
第 15 卷, 第 5 期
DOI
10.1002/wnan.1892
语言
ENGLISH
成果收录
SCIE
资助标注
Guangdong Provincial Pearl River Talents Program [2017GC010713]; Guangdong Basic and Applied Basic Research Foundation [2022B1515020058]; National Key R&D Program of China [2021YFB3800900]; National Natural Science Foundation of China [52130301, 32071380]; Science and Technology Program of Guangzhou [202103030004]

作者

  • Z

    Zhao, Dong-Kun (第一作者)

  • L

    Liang, Jie

查看全部 5 位作者收起作者
  • H

    Huang, Xiao-Yi (通讯)

  • S

    Shen, Song (通讯)

  • W

    Wang, Jun (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417